TrialBritish journal of cancer2016

Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial.

Yoshitomo Yanagimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.